HALO logo
halo search icon
Pharming Group NV Sponsored ADR

US$12.87

Price Change Indicator
0.27 (2.14%)
Pharming Group NV Sponsored ADR
PHAR · NAS

Pharming Group NV Sponsored ADR

Start Trading PHAR for Free

US$12.87

Price Arrow0.27 (2.14%)
20/05/2026 03:50:10 PM
All-ConsensusConsensus Cheap
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Pharming Group NV Sponsored ADR Overview

PHAR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About PHAR

icon

Website

Pharming Group NV Sponsored ADR

icon

Telephone

31.71.524.74.00

icon

Address

Vondellaan 47, Leiden, Zuid-Holland 2332 AA

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

PHAR Price Chart

Key Stats

Market Cap

US$895.58M

PE

425.80

EV/EBITDA

39.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 9.54 - 21.34

Trade Value (12mth)

US$67,302.00

1 week

-2.48%

1 month

-26.44%

YTD

-26.49%

1 year

20.11%

All time high

21.99

Key Fundamentals

EPS 3 yr Growth

-80.30%

EBITDA Margin

8.40%

Operating Cashflow

$50m

Free Cash Flow Return

14.00%

ROIC

0.80%

Interest Coverage

2.90

Quick Ratio

2.00

Other Data

Shares Outstanding (Fully Diluted)

70m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PHAR Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
16 April 26
14 April 26
02 April 26

PHAR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.16-0.180.04locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.16-0.180.04locklocklock
Growth
 %locklocklocklock-176.2-9.6123.6locklocklock
PE
 XlocklocklocklockN/AN/A425.8locklocklock
EV/EBITDA
 XlocklocklocklockN/A84.239.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Pharming Group NV Sponsored ADR (PHAR:NAS)?
Halo FAQ
The current share price of Pharming Group NV Sponsored ADR (PHAR:NAS) is USD$12.87.
What is the 52-week high share price for Pharming Group NV Sponsored ADR (PHAR:NAS)?
Halo FAQ
The 52-week high share price for Pharming Group NV Sponsored ADR (PHAR:NAS) is USD$21.34.
What is the 52-week low share price for Pharming Group NV Sponsored ADR (PHAR:NAS)?
Halo FAQ
The 52-week low share price for Pharming Group NV Sponsored ADR (PHAR:NAS) is USD$9.54.
What is the dividend yield for Pharming Group NV Sponsored ADR (PHAR:NAS)?
Halo FAQ
Pharming Group NV Sponsored ADR (PHAR:NAS) does not pay a dividend.
What was Pharming Group NV Sponsored ADR (PHAR:NAS) last dividend payment?
Halo FAQ
Pharming Group NV Sponsored ADR (PHAR:NAS) does not pay a dividend.
What is the franking level for Pharming Group NV Sponsored ADR (PHAR:NAS)?
Halo FAQ
Pharming Group NV Sponsored ADR (PHAR:NAS) has a franking level of 0.00%.
In which sector is Pharming Group NV Sponsored ADR (PHAR:NAS) classified?
Halo FAQ
Pharming Group NV Sponsored ADR (PHAR:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Pharming Group NV Sponsored ADR (PHAR:NAS)?
Halo FAQ
The current P/E ratio for Pharming Group NV Sponsored ADR (PHAR:NAS) is 425.80.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial